Alterity Therapeutics Limited Gains 64.62%
Alterity Therapeutics Limited (ATHE:NASDAQ) shot up at $2.14, a gain of 64.6%. The stock got featured on our News Catalysts scanner on Thu, Jul 01, 2021 at 04:43 PM in the 'ACQUISITION' category. From Wed, Jun 16, 2021, the stock recorded 40.00% Up Days and 54.55% Green Days
The stock spiked on Tue, Feb 09, 2021 at $2.48 with a volume of 6M+, and its share price has been moving sideways in recent weeks.
About Alterity Therapeutics Limited (ATHE:NASDAQ)
Prana Biotechnology Ltd is active in the healthcare domain. The company is engaged in research collaboration with Takeda for the treatment of Parkinson's disease gastrointestinal neuropathology. The company's lead drug candidate-PBT2 is being developed for the treatment of Alzheimer's and Huntington's diseases. It has also advanced a drug candidate for Parkinson's disease and other movement disorders (PBT434) and brain cancer (PBT519), which are in pre-clinical toxicology testing.
Top 10 Gainers:
- BSKY (BSKY:NASDAQ), 2589.63%
- CPOP (CPOP:NASDAQ), 97.69%
- Alterity Therapeutics Limited (ATHE:NASDAQ), 64.62%
- Trxade Group, Inc. (MEDS:NASDAQ), 62.59%
- Marin Software Incorporated (MRIN:NASDAQ), 40.54%
- Bridgeline Digital, Inc. (BLIN:NASDAQ), 33.72%
- AUUD (AUUD:NASDAQ), 30.32%
- Birks Group Inc. (BGI:NYSEMKT), 29.36%
- Pulse Biosciences, Inc. (PLSE:NASDAQ), 26.95%
- Grid Dynamics Holdings, Inc. (GDYN:NASDAQ), 25.08%